Ardent Health Recharacterizes CEO Departure as 'Cause', Halts $4.5M Severance
Ardent Health, Inc. announced that it has recharacterized the separation of former President and CEO Martin J. Bonick as a termination for 'Cause'. This decision follows a Board review which determined that Bonick failed to fully disclose compensation received from third parties. As a result, the Company will cease remaining severance payments, including approximately $4.5 million in unpaid cash severance, and all unvested PRSUs will be forfeited. The Company reserves its right to pursue further remedies.
Key Highlights
- Ardent Health recharacterized former CEO Martin J. Bonick's separation as a termination for 'Cause'.
- Bonick failed to disclose compensation received from third parties.
- Company will discontinue remaining severance payments of approximately $4.5 million.
- Outstanding unvested performance-based restricted stock units (PRSUs) will be cancelled.
Price Impact
More from ARDT
Ardent Health Q2 Net Income Attributable to Company $16.9M, down from $73.0M
Ardent Health Q2 Net Income $17M; Adjusted EBITDA $115M; Reaffirms FY26 Guidance
Ardent Health Finalizes Separation Agreement with Former CEO Martin Bonick